Home Newsfeeds U.S. Senator Manchin Secured Commitment From Biden Administration to Allow Mountain Valley Pipeline to Be Completed

U.S. Senator Manchin Secured Commitment From Biden Administration to Allow Mountain Valley Pipeline to Be Completed

Reuters Citing CBS Affiliate, Citing Statement from Manchin's Office

byCharles Gross

August 1, 2022

1 minute read

Reuters Citing CBS Affiliate, Citing Statement from Manchin’s Office

Morgan Stanley Initiates Coverage On Focus Finl Partners with Underweight Rating, Announces Price Target of $37

By Benzinga Newsdesk

September 20, 6:14 AM

Morgan Stanley analyst Ryan Kenny initiates coverage on Focus Finl Partners (NASDAQ:FOCS) with a Underweight rating and announces Price Target of $37.

FOCS

JP Morgan Initiates Coverage On Xencor with Overweight Rating, Announces Price Target of $37

By Benzinga Newsdesk

September 21, 7:41 AM

JP Morgan analyst Brian Cheng initiates coverage on Xencor (NASDAQ:XNCR) with a Overweight rating and announces Price Target of $37.

XNCR

News
Tech

Microsoft Will Surpass Apple, Google And Meta To Become ‘Sole’ Big Tech Leader On The Back Of ChatGPT, Says Expert

By Ananya Gairola

January 17, 6:06 AM

Microsoft Corporation (NASDAQ:MSFT) will soon add OpenAI’s artificial intelligence, or AI chatbot, chatGPT, to its cloud-based Azure services,…

AAPL

Starton Therapeutics Receives Authorization From The FDA To Proceed With STAR-LLD Lenalidomide Phase 1b Clinical Trial In Multiple Myeloma

By Benzinga Newsdesk

June 12, 4:32 PM

FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myelomaTreatment regimen will include Velcade® (bortezomib) and dexamethasone and replace oral Revlimid® with

HWEL

U.S. Senator Manchin Secured Commitment From Biden Administration to Allow Mountain Valley Pipeline to Be Completed

Related Posts

Morgan Stanley Initiates Coverage On Focus Finl Partners with Underweight Rating, Announces Price Target of $37

JP Morgan Initiates Coverage On Xencor with Overweight Rating, Announces Price Target of $37

Microsoft Will Surpass Apple, Google And Meta To Become ‘Sole’ Big Tech Leader On The Back Of ChatGPT, Says Expert

Starton Therapeutics Receives Authorization From The FDA To Proceed With STAR-LLD Lenalidomide Phase 1b Clinical Trial In Multiple Myeloma